On February 25, 2019, jinan successfully held the jinan (Tokyo) health industry cooperation and exchange meeting in Tokyo, Japan.

As one of the outstanding representatives of health industry in jinan city, yingsheng biological co., ltd. was invited to participate in this cooperation exchange meeting and introduce the current business fields and cooperation needs of yingsheng biological co., LTD.

The meeting was jointly organized by jinan investment promotion bureau, Japan trade promotion agency and pricewaterhousecoopers, focusing on attracting investment to Japan for the biomedical and health care industries in jinan.
It was attended by representatives from 24 Japanese enterprises and institutions including sumitomo corporation, yuanqi village group, changsheng pension corporation and cell therapy technology institute.The two sides conducted pragmatic exchanges on the development trend of the big health industry and project cooperation.

Guo quantao, chief representative of the economic and trade representative office of shandong government in Japan, and li zijun, vice mayor of jinan attended the event and delivered a speech.

During the seminar, the Mr Sheng Feng Zhen biological founder and chairman of the board of directors/general manager to the guest attending the meeting on behalf of ying sheng biological introduced the development of the company, the creature is clinical Chinese mass spectrometry one-stop solution for leaders, is the collection of medical equipment research and development, production and sales, and the third party medical test services for the integration of high-tech enterprises.

Relying on the international advanced level of scientific research innovation ability and the deepening of Chinese clinical market tired solid foundation, ying sheng biology around the life and health service is gradually build complete including intelligence before processing equipment, precision mass spectrum detection equipment and large data center "quality" of China, made the whole chain mass spectrometry ecosystem, and successively developed based on mass spectrometry detection technology platform development of genetic metabolic disease screening kit (48, domestic initiative), full spectrum vitamin detection kit (14, domestic exclusive), full spectrum mineral detection kit.

Developed based on the gene diagnosis platform, the deafness gene detection kit (the first in China with detachable loci), the folic acid metabolic capacity detection kit, the b-27 detection kit and other clinical reagents.

Yingsheng biotechnology has always adhered to the principle of "customer first, technical support, wisdom and wisdom", and constantly meet customer needs to achieve win-win cooperation.